Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224264 | SCV000281050 | benign | not provided | 2015-06-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000422754 | SCV000524255 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445464 | SCV000536992 | benign | Monogenic diabetes | 2019-02-08 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL score 0.034 + 8 predictors), BA1 (7.4% in gnomAD African) , BS2(70 homozygotes in gnomAD), BP1 (missense when truncating causes disease)= benign |
Invitae | RCV001082984 | SCV000554311 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000422754 | SCV000711835 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Ser3684Asn in exon 16 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 7.58% (734/9688) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs11896293). |
Athena Diagnostics | RCV000224264 | SCV001142995 | benign | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001082984 | SCV002506012 | benign | Alstrom syndrome | 2023-09-06 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV001082984 | SCV002605267 | benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs11896293 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002433942 | SCV002745394 | benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001082984 | SCV001455021 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000224264 | SCV001800044 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000422754 | SCV001930122 | benign | not specified | no assertion criteria provided | clinical testing |